New drug combo shows promise in relieving pain, symptoms
A recent clinical study, conducted at the University of Bath in England with women of reproductive age, demonstrated great potential of a new drug combination. The two drugs are E2MATE – created in the university’s Department of Pharmacy & Pharmacology – and norethindrone acetate, or traditional progesterone.
Researchers must test the drug combination further in human trials to confirm that it will be an effective treatment of endometriosis, but it shows great promise.
The drugs work to starve the endometrial tissue and prevent it from growing.
With the combined treatment, the cells grew even less. With less growth, the patient sees fewer symptoms of pain and infertility, and may eventually see none at all.
